Search Within

Jeremy J Pappacena

Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
  3. Review (1)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Adult Leukemia (3)
  5. Bone Marrow Transplant (3)
  6. DigITs Research Group (3)

More Groups

People
  1. Amber King (3)
  2. Larry Buie (3)
  3. Martin Tallman (3)
  4. Molly Maloy (3)
  5. Patrick Hilden (3)
  6. Valkal Bhatt (3)

More People

Years
  1. 2019 (3)
  2. 2018 (3)
  3. 2017 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (2)
  2. Blood (2)
  3. Annals of Pharmacotherapy (1)
  4. Blood Advances (1)
  5. Leukemia Research (1)
Publishers
  1. American Society of Hematology (3)
  2. Elsevier Inc. (2)
  3. Elsevier Ltd (1)
  4. Sage Publications (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Busulfan/melphalan/fludarabine (Bu/Mel/Flu) conditioning versus total body irradiation/thiotepa/cyclophosphamide (HFTBI/Thio/Cy) based conditioning in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing CD34-selected T-cell depleted allogeneic stem cell transplantation (alloSCT)
    Meeting Abstract

    Orozco, J. S.; Hilden, P.; Maloy, M. A.; Pappacena, J.; Buie, L. W.; Shaffer, B. C.; Papadopoulos, E. B.; Jakubowski, A. A.; Bhatt, V.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • No loose ends: A review of the pharmacotherapy of hairy cell and hairy cell leukemia variant
    Review

    King, A. C.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Daley, R. J.
    Annals of Pharmacotherapy (2019)

    Fulltext@MSK | Save
  • Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
    Journal Article

    King, A. C.; Pappacena, J. J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
    Leukemia Research (2019)

    Fulltext@MSK | Save
  • Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
    Journal Article

    Xiao, W.; Yabe, M.; Offin, M.; Khattar, P.; Baik, J.; Daley, R. J.; Pappacena, J. J.; Roshal, M.; Zhang, Y.; Tallman, M. S.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
    Meeting Abstract

    King, A. C.; Pappacena, J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
    Blood (2018)

    Fulltext@MSK | Save
  • More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (allo-HCT)
    Meeting Abstract

    Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (Allo-HCT)
    Meeting Abstract

    Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
    Blood (2017)

    Fulltext@MSK | Save